Loading organizations...
Loading organizations...
Biopharmaceutical company developing non-opioid cannabinoid therapeutics.
Kannalife has raised $3.0M across 2 funding rounds.
Kannalife has raised $3.0M in total across 2 funding rounds.
Kannalife has raised $3.0M in total across 2 funding rounds.
Kannalife's investors include The Michael J. Fox Foundation for Parkinson's Research.
Kannalife has raised $3.0M across 2 funding rounds. Most recently, it raised $1.5M Grant in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 25, 2024 | $1.5M Grant | The Michael J. Fox Foundation for Parkinson's Research | |
| Mar 7, 2013 | $1.5M Series A |